MicroRNA-218 enhances the radiosensitivity of human cervical cancer via promoting radiation induced apoptosis

International Journal of Medical Sciences

Volumn 11, Issue 7, 2014, Pages 691-696

  Yuan, Wang ^a,b   Xiaoyun, Han ^c   Haifeng, Qiu ^d   Jing, Li ^e   Weixu, Hu ^f   Ruofan, Dong ^b   Jinjin, Yu ^b   Zongji, Shen ^a,g  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b Soochow University   (China)

^c SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

^e SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^f ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^g NONE   (China)

Author keywords

Cervical cancer; MiR 218; Radiotherapy; Sensitivity

Indexed keywords

MICRORNA; MICRORNA 218; UNCLASSIFIED DRUG; MIRN218 MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; HELA CELL LINE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; RADIOSENSITIVITY; TUMOR XENOGRAFT; UTERINE CERVIX CANCER; ADULT; BIOSYNTHESIS; CELL PROLIFERATION; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; RADIATION DOSE; RADIATION RESPONSE; UTERINE CERVICAL NEOPLASMS;

ADULT; APOPTOSIS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MICRORNAS; MIDDLE AGED; RADIATION TOLERANCE; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84900417035     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.8880     Document Type: Article

References (19)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2011; 127: 2893-2917.
3. Zhao FH, Hu SY, Zhang SW, Chen WQ, Qiao YL. [Cervical cancer mortality in 2004 -2005 and changes during last 30 years in China]. Zhonghua Yu Fang Yi Xue Za Zhi. 2010; 44: 408-412.
4. National Office for Cancer Prevention and Control N, Central Cancer Registry DPaC, Health BMo. Chinese Cancer; Registry Annual Report 2008. Beijing: Military Medical Science Press. 2009.
5. Shi JF, Canfell K, Lew JB, Qiao YL. The burden of cervical cancer in China: synthesis of the evidence. Int J Cancer. 2011; 130: 641-652.
6. Moore DH. Cervical cancer. Obstet Gynecol. 2006; 107: 1152-1161.
7. Rogers L, Siu SS, Luesley D, Bryant A, Dickinson HO. Radiotherapy and chemora-diation after surgery for early cervical cancer. Cochrane Database Syst Rev. 2012; 5: CD007583.
8. Nakano T, Kato S, Ohno T, Tsujii H, Sato S, Fukuhisa K, et al. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix. Cancer. 2005; 103: 92-101.
9. Powell ME. Modern radiotherapy and cervical cancer. Int J Gynecol Cancer. 2010; 20: S49-S51.
10. Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S, et al. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet. 2010; 6: e1000879.
11. Gien LT, Beauchemin MC, Thomas G. Adenocarcinoma: a unique cervical cancer. Gynecol Oncol. 2010; 116: 140-146.
12. Weidhaas JB, Babar I, Nallur SM, Trang P, Roush S, Boehm M, et al. MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res. 2007; 67: 11111-11116.
13. Josson S, Sung SY, Lao K, Chung LW, Johnstone PA. Radiation modulation of microRNA in prostate cancer cell lines. Prostate. 2008; 68: 1599-1606.
14. Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F, Xiao Y, Guang-Xiu W, et al. Mi-croRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer. 2010; 10: 367.
15. Yu J, Wang Y, Dong R, Huang X, Ding S, Qiu H. Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion. J Cancer Res Clin Oncol. 2012; 138: 671-674.
16. Gao C, Zhang Z, Liu W, Xiao S, Gu W, Lu H. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer. 2009; 116: 41-49.
17. He X, Dong Y, Wu CW, Zhao Z, Ng SS, Chan FK, et al. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene. Mol Med. 2012; 18: 1491-1498.
18. [Internet] ClinicalTrials.gov. Miravirsen in Combination With Telaprevir and Rib-avirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Infection. http://clinicaltrials.gov/ ct2/show/NCT01872936?term=NCT01872936&rank=1.
19. [Internet] ClinicalTrials.gov. A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposome Injectable Suspension. http://clinicaltrials.gov/ ct2/show/NCT01829971?term=NCT01829971&rank=1.